BRPI0810959A2 - "proteína l1 do hpv11, polinucleotídeo, vetor, célula, composição, partícular semelhante ao vírus (vlp) hp11, método para produzir uma proteína l1 do hpv,vacina para prevenção de condiloma acuminado ou de infecções por hpv, uso da proteína método para prevenção de condiloma acuminado ou infecções por hpv e método para prevenção de condiloma acuminado ou infecções por hpv. - Google Patents

"proteína l1 do hpv11, polinucleotídeo, vetor, célula, composição, partícular semelhante ao vírus (vlp) hp11, método para produzir uma proteína l1 do hpv,vacina para prevenção de condiloma acuminado ou de infecções por hpv, uso da proteína método para prevenção de condiloma acuminado ou infecções por hpv e método para prevenção de condiloma acuminado ou infecções por hpv.

Info

Publication number: BRPI0810959A2
Authority: BR; Brazil
Prior art keywords: protein; prevention; hpv; hpv infections; condyloma
Prior art date: 2007-05-29

Application number

BRPI0810959-1A

Other languages

English (en)

Inventor

Jun Zhang

Jin Wang

Chunyan Yang

Ying Gu

Shaowei Li

Ningshoa Xia

Original Assignee

Xiamen University E Outro

Beijing Wantai Biological Pharmacy Entpr Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-29

Filing date

2008-05-29

Publication date

2015-07-21

2008-05-29 Application filed by Xiamen University E Outro, Beijing Wantai Biological Pharmacy Entpr Co Ltd filed Critical Xiamen University E Outro

2015-07-21 Publication of BRPI0810959A2 publication Critical patent/BRPI0810959A2/pt

2021-06-29 Publication of BRPI0810959B1 publication Critical patent/BRPI0810959B1/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Microbiology (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Mycology (AREA)
Biophysics (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BRPI0810959-1A 2007-05-29 2008-05-29 Proteína l1 do hpv11, polinucleotídeo, vetor, célula, composição, partícula do tipo vírus (vlp) hpv11, método para produzir uma proteína l1 do hpv, vacina para prevenção de condiloma acuminado ou de infecções por hpv e método para produzir uma vacina para prevenção de condiloma acuminado ou infecções por hpv BRPI0810959B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CN200710105763.2		2007-05-29
CN200710105763		2007-05-29
PCT/CN2008/001049 WO2008145020A1 (fr)	2007-05-29	2008-05-29	Protéine l1 tronquée du papillomavirus 11 humain

Publications (2)

Publication Number	Publication Date
BRPI0810959A2 true BRPI0810959A2 (pt)	2015-07-21
BRPI0810959B1 BRPI0810959B1 (pt)	2021-06-29

Family

ID=40074566

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0810959-1A BRPI0810959B1 (pt)	2007-05-29	2008-05-29	Proteína l1 do hpv11, polinucleotídeo, vetor, célula, composição, partícula do tipo vírus (vlp) hpv11, método para produzir uma proteína l1 do hpv, vacina para prevenção de condiloma acuminado ou de infecções por hpv e método para produzir uma vacina para prevenção de condiloma acuminado ou infecções por hpv

Country Status (6)

Country	Link
US (3)	US9533035B2 (pt)
EP (3)	EP2154148B1 (pt)
CN (1)	CN101343314B (pt)
BR (1)	BRPI0810959B1 (pt)
DK (3)	DK2907821T3 (pt)
WO (1)	WO2008145020A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101293918B (zh) *	2007-04-29	2013-03-27	北京万泰生物药业股份有限公司	截短的人乳头瘤病毒16型l1蛋白
CN101570571B (zh)	2007-04-29	2012-07-11	北京万泰生物药业股份有限公司	截短的人乳头瘤病毒18型l1蛋白
BRPI0810951B8 (pt) *	2007-05-29	2021-05-25	Beijing Wantai Biological Pharmacy Entpr Co Ltd	proteína l1 do hpv6, polinucleotídeo, vetor, célula, partícula semelhante ao vírus (vlp) hpv6, método para produzir a proteína hpv6 l1 truncada, vacina para prevenção de condiloma acuminado ou de infecções por hpv, uso da proteína hpv6 l1 truncada, método para prevenção de condiloma acuminado ou infecções por hpv, método para obter uma vlp de uma proteína l1 do hpv6 e método para produzir uma vacina para a prevenção de condiloma acuminado ou de infecções por hpv
US9499591B2 (en)	2010-07-02	2016-11-22	Xiamen University	Truncated L1 protein of human papillomavirus type 52
CN102229660B (zh)	2011-05-25	2015-04-22	厦门大学	截短的人乳头瘤病毒33型l1蛋白
KR101559622B1 (ko)	2012-07-30	2015-10-13	중앙대학교 산학협력단	인유두종바이러스 바이러스 유사입자의 고효율 정제방법
CN105177025B (zh) *	2013-12-03	2022-11-01	北京康乐卫士生物技术股份有限公司	18型重组人乳头瘤病毒病毒样颗粒及其制备方法
WO2017092711A1 (zh) *	2015-12-04	2017-06-08	厦门大学	一种人乳头瘤病毒11型l1蛋白的突变体
CN106831960B (zh) *	2015-12-04	2019-11-05	厦门大学	一种人乳头瘤病毒6型l1蛋白的突变体
WO2021013069A1 (zh) *	2019-07-19	2021-01-28	神州细胞工程有限公司	嵌合的人乳头瘤病毒11型l1蛋白
CN114539363B (zh) *	2020-11-26	2023-12-01	中国医学科学院基础医学研究所	一种c端改造的人乳头瘤病毒11型l1蛋白及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0688227B1 (en)	1993-03-09	2005-05-25	The University Of Rochester	Production of human papillomavirus capsid protein and virus-like particles
US20020193565A1 (en) *	1998-03-27	2002-12-19	Stanley Margaret Anne	Antigen preparation and use
AU3730600A (en)	1999-03-18	2000-10-04	Xiaojiang Chen	Compositions preparations and uses of human papillomavirus l1 protein
CN1290859C (zh)	2001-08-31	2006-12-20	开普敦大学	关于hpv－11和hpv－16l1衣壳蛋白的载体,构建体,和转基因植物
GB0206359D0 (en) *	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
AU2003228816A1 (en) *	2002-05-02	2003-11-17	Boyce Thompson Institute For Plant Research, Inc.	Production of papillomavirus vaccines in plants
CN1293093C (zh) *	2002-08-30	2007-01-03	马润林	乳头瘤病毒衣壳蛋白的原核制备和应用
CN1683010A (zh)	2005-02-06	2005-10-19	哈尔滨医科大学	人乳头瘤病毒型双价病毒样颗粒混合蛋白抗原及构建方法
CN101153280B (zh)	2006-09-29	2015-08-19	厦门大学	从原核生物中纯化人乳头瘤病毒晚期蛋白l1的方法

2008
- 2008-05-29 BR BRPI0810959-1A patent/BRPI0810959B1/pt active IP Right Grant
- 2008-05-29 DK DK15160399.0T patent/DK2907821T3/en active
- 2008-05-29 DK DK08757380.4T patent/DK2154148T3/en active
- 2008-05-29 US US12/601,983 patent/US9533035B2/en active Active
- 2008-05-29 CN CN200810111389.1A patent/CN101343314B/zh active Active
- 2008-05-29 WO PCT/CN2008/001049 patent/WO2008145020A1/zh not_active Ceased
- 2008-05-29 EP EP08757380.4A patent/EP2154148B1/en active Active
- 2008-05-29 EP EP15160399.0A patent/EP2907821B1/en active Active
- 2008-05-29 DK DK15160363.6T patent/DK2910566T5/en active
- 2008-05-29 EP EP15160363.6A patent/EP2910566B1/en active Active
2016
- 2016-11-14 US US15/350,264 patent/US9943586B2/en active Active
2018
- 2018-03-19 US US15/924,511 patent/US10537629B2/en active Active

Also Published As

Publication number	Publication date
US9943586B2 (en)	2018-04-17
HK1208473A1 (en)	2016-03-04
US20170065708A1 (en)	2017-03-09
EP2154148B1 (en)	2016-06-22
WO2008145020A1 (fr)	2008-12-04
DK2154148T3 (en)	2016-09-19
EP2154148A4 (en)	2011-01-05
DK2910566T5 (en)	2016-11-07
EP2154148A1 (en)	2010-02-17
US20100291141A1 (en)	2010-11-18
HK1124344A1 (zh)	2009-07-10
EP2910566A1 (en)	2015-08-26
DK2907821T3 (en)	2017-04-10
EP2910566B1 (en)	2016-07-13
EP2907821B1 (en)	2016-12-28
EP2907821A1 (en)	2015-08-19
CN101343314A (zh)	2009-01-14
BRPI0810959B1 (pt)	2021-06-29
DK2910566T3 (en)	2016-10-24
CN101343314B (zh)	2015-11-25
US9533035B2 (en)	2017-01-03
US20180207257A1 (en)	2018-07-26
US10537629B2 (en)	2020-01-21

Similar Documents

Publication	Publication Date	Title
BRPI0810959A2 (pt)	2015-07-21	"proteína l1 do hpv11, polinucleotídeo, vetor, célula, composição, partícular semelhante ao vírus (vlp) hp11, método para produzir uma proteína l1 do hpv,vacina para prevenção de condiloma acuminado ou de infecções por hpv, uso da proteína método para prevenção de condiloma acuminado ou infecções por hpv e método para prevenção de condiloma acuminado ou infecções por hpv.
BRPI0810951A2 (pt)	2015-07-21	Proteína l1 hpv6, polinucleotídeo, vetor, célula, composição, partícula semelhante ao vírus (vlp) hpv6, método para produzir uma proteína l1 do hpv, vacina para prevenção de condiloma acuminado ou de infecções porhpv, uso da proteína, método para prevenção de condiloma acuminado ou infecções por hpv, método pra obter uma vlp de uma proteína l1 do hpv6 e método para produzir uma vacina para a prevenção de condiloma acuminado ou de infecções por hpv
EP4215543A3 (en)	2023-10-11	Hpv-specific binding molecules
WO2008061243A3 (en)	2008-10-16	Respiratory syncytial virus-virus like particle (vlps)
EP1917033A4 (en)	2009-09-02	VIRUS LIKE PARTICLES AS PARAMYXOVIRUS VACCINES
BRPI0916235A2 (pt)	2018-03-13	composto, composição farmacêutica, uso do composto ou da composição, e, método para tratar um paciente infectado com hcv
WO2007095320A3 (en)	2007-10-25	Hpv antigens, vaccine compositions, and related methods
EP1971655A4 (en)	2012-09-05	UV-CURABLE AQUEOUS EMULSION, ITS PREPARATION AND SOLVENT-FREE COATING COMPOSITION THEREWITH
WO2006075245A3 (en)	2007-11-15	Systems, methods, and compositions for detection of human papilloma virus in biological samples
BRPI0816330A2 (pt)	2015-04-14	Composição de polipeptídeo, método para produzir composição de polipeptídeo, construção de polipeptídeo, método para produzir uma construção de polipeptídeo, construção de ácido nucleico, medicamento ou composição de vacina, método para produzir um medicamento ou composição de vacina, e uso da composição de polipeptídeo, de uma construção de polipeptídeo, de uma construção de ácido nucléico ou de um medicamento ou de composição de vacina
WO2010001409A3 (en)	2010-05-27	Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same
WO2010101967A3 (en)	2010-11-11	Phosphothiophene and phosphothiazole hcv polymerase inhibitors
WO2009009759A3 (en)	2009-07-16	Yersinia pestis antigens, vaccine compositions, and related methods
WO2008034388A8 (en)	2009-07-09	Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof
WO2013006569A3 (en)	2013-04-11	Herpes virus vaccine and methods of use
WO2017192418A8 (en)	2019-05-23	Therapeutic hpv vaccine combinations
WO2008048976A3 (en)	2008-11-20	Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors
HUS1500061I1 (hu)	2016-01-28	A HPV16 és HPV18 és a HPV 31, 45 vagy 52 közül legalább egy másik HPV típus elleni vakcina
BRPI0818718B8 (pt)	2021-05-25	processo de preparo de uma composição de vacina compreendendo antígeno e adjuvante na forma de látex inverso de homopolímero do ácido acrílico
WO2010033619A3 (en)	2010-06-24	Systems, methods, and compositions for detection of human papilloma virus in biological samples
WO2012036437A3 (ko)	2012-06-28	면역성 펩타이드 및 그 펩타이드를 포함하는 ｈｐｖ 관련 질환 예방 또는 치료용 조성물
AR041515A1 (es)	2005-05-18	Vacuna a dna contra el virus de papiloma humano
WO2009117185A3 (en)	2010-07-01	Nondegradable hydrogels for medical device application
BRPI0512042B8 (pt)	2021-05-25	composição imunogênica, vacina, uso de uma composição ou vacina, método para produzir uma composição imunogênica, e, uso de vlps ou capsômeros de hpv 16 e 18 com vlps ou capsômeros de pelo menos um outro hpv do tipo causador de câncer
MX2014000522A (es)	2014-05-30	Composicion y metodo para tratar virus del papiloma humano (vph).

Legal Events

Date	Code	Title	Description
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-10-23	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2019-12-31	B25A	Requested transfer of rights approved	Owner name: XIAMEN UNIVERSITY E OUTRO (CN) ; XIAMEN INNOVAX BI
2020-05-05	B07E	Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-08-25	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2021-02-09	B06A	Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
2021-05-25	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-06-29	B16A	Patent or certificate of addition of invention granted	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/05/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, , QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.